| The impact of m6A RNA modification in therapy resistance of cancer: implication in chemotherapy, radiotherapy, and immunotherapy O Shriwas, P Mohapatra, S Mohanty, R Dash Frontiers in Oncology 10, 612337, 2021 | 56 | 2021 |
| CMTM6 drives cisplatin resistance by regulating Wnt signaling through the ENO-1/AKT/GSK3β axis P Mohapatra, O Shriwas, S Mohanty, A Ghosh, S Smita, SR Kaushik, ... JCI insight 6 (4), 2021 | 48 | 2021 |
| RRBP1 rewires cisplatin resistance in oral squamous cell carcinoma by regulating Hippo pathway O Shriwas, R Arya, S Mohanty, P Mohapatra, S Kumar, R Rath, ... British Journal of Cancer 124 (12), 2004-2016, 2021 | 20 | 2021 |
| Graphene and graphene oxide as nanomaterials for medicine and biology application, J. Nanostructure Chem. 8 (2018) 123–137 S Priyadarsini, S Mohanty, S Mukherjee, S Basu, M Mishra | 10 | |
| Graphene and graphene oxide as nanomaterials for medicine and biology application. J Nanostruct Chem 8: 123–137 S Priyadarsini, S Mohanty, S Mukherjee, S Basu, M Mishra | 9 | 2018 |
| CRISPR-based kinome-screening revealed MINK1 as a druggable player to rewire 5FU-resistance in OSCC through AKT/MDM2/p53 axis S Mohanty, P Mohapatra, O Shriwas, SA Ansari, M Priyadarshini, ... Oncogene 41 (45), 4929-4940, 2022 | 6 | 2022 |
| CMTM6 attenuates cisplatin‐induced cell death in OSCC by regulating AKT/c‐Myc‐driven ribosome biogenesis P Mohapatra, S Mohanty, SA Ansari, O Shriwas, A Ghosh, R Rath, ... The FASEB Journal 36 (10), e22566, 2022 | 5 | 2022 |
| Studies on the effect of dietary organic acids on performance of commercial broilers D Thirumeignanam, RK Swain, S Mohanty, PK Patil Abst. ANCON 27, 161, 2006 | 5 | 2006 |
| Three-dimensional tumor model and their implication in drug screening for tackling chemoresistance M Priyadarshini, S Mohanty, T Mahapatra, P Mohapatra, R Dash Biomaterials for 3D Tumor Modeling, 481-503, 2020 | 3 | 2020 |
| Correction: RRBP1 rewires cisplatin resistance in oral squamous cell carcinoma by regulating Hippo pathway O Shriwas, R Arya, S Mohanty, P Mohapatra, S Kumar, R Rath, ... British Journal of Cancer 124 (12), 2039, 2021 | 2 | 2021 |
| Feeding Artemia nauplii enriched with the probiotic bacterium Bacillus subtilis improved growth performance, survival and digestive enzyme activity of Clarias batrachus … SP Kamble, AK Sahu, S Mohanty, SK Sahoo, K Murmu, C Prakash, ... Indian Journal of Fisheries 66 (2), 2019 | 2 | 2019 |
| Tolypothrix Dichloromethane Ethylacetate fraction (TDEF) inhibits cisplatin resistance H357 cell through PI3K/AKT/beta-catenin pathway R Heisnam, ST Devi, S Mohanty, PK Mukherjee, VVSPK Rayala, ... American Journal of Cancer Research 14 (3), 1071, 2024 | | 2024 |
| CMTM6 mediates cisplatin resistance in OSCC by regulating AKT/c-MYC driven ribosome biogenesis P Mohapatra, S Mohanty, SA Ansari, O Shriwas, A Ghosh, R Rath, ... bioRxiv, 2022.04. 08.487634, 2022 | | 2022 |
| MINK1 modulates 5FU resistance in OSCC through AKT/MDM2 mediated regulation of p53 S Mohanty, P Mohapatra, O Shriwas, M Priyadarshini, SA Ansari, ... bioRxiv, 2021.08. 19.456939, 2021 | | 2021 |
| RRBP1 rewires cisplatin resistance in Oral Squamous Cell Carcinoma by regulating YAP-1 O Shriwas, R Arya, S Mohanty, S Kumar, R Rath, SR Kaushik, MC Thakur, ... bioRxiv, 2020.03. 18.998070, 2020 | | 2020 |
| CMTM6 drives cisplatin resistance in OSCC by regulating AKT mediated Wnt signaling P Mohapatra, O Shriwas, S Mohanty, SR Kaushik, R Arya, R Rath, ... bioRxiv, 2020.03. 18.993774, 2020 | | 2020 |
| EhRho1 regulates cell motility and phagocytosis in Entamoeba histolytica. R Bharadwaj, R Arya, A Bhattacharya, S Bhattacharya, S Mohanty MOLECULAR BIOLOGY OF THE CELL 28, 2017 | | 2017 |
| MINK1 modulates 5FU resistance in OSCC through AKT/MDM2 mediated regulation of p53. One sentence summary: Lestaurtinib reverses 5FU sensitivity in drug resistant OSCC. S Mohanty, P Mohapatra, O Shriwas, M Priyadarshini, SA Ansari, ... | | |
